FILTER

Refine your search with the following facets to narrow down your results.

6 Current news of Luminex

Merck sells its Flow Cytometry unit for €62.5 million

19-Oct-2018 - Merck announced the signing of a definitive agreement to sell its Flow Cytometry unit to Luminex Corporation for €62.5 million. The closing of the transaction, expected by the end of 2018, is subject to customary closing conditions. Upon completion of the transaction, Luminex will own the flow ...

acquisitions flow cytometers flow cytometry +1

Luminex Corporation Names Tim Dehne Vice President of Systems and Research and Development

14-Jul-2009 - Luminex Corporation announced the appointment of Tim Dehne to the position of Vice President, Systems Research and Development, effective July 20, 2009. Mr. Dehne is an accomplished executive in engineering and product development, with vast experience in the technology sector. He joins Luminex ...

project management

Luminex Corporation and ViroNovative Announce License Agreement for Human Metapneumovirus Rights

16-Jul-2008 - Luminex Corporation and ViroNovative BV announced that the companies have signed a licensing agreement that gives Luminex worldwide rights to use ViroNovative's human metapneumovirus (hMPV) intellectual property in the xTAG Respiratory Viral Panel (RVP). Under the terms of the agreement, rights ...

acids food license agreements +4

Wageningen UR and Luminex develop multiplex detection for the agricultural and food industries

23-Apr-2008 - Plant Research International, a division of Wageningen UR, and Luminex Corporation have signed a licensing agreement for the use of xMAP(r) technology. This will allow Plant Research International to further extend its research and product portfolio. The institute expects xMAP to result in new ...

diagnostics food laboratories +3

TM Bioscience shareholders and optionholders approve proposed acquisition by Luminex Corporation

27-Feb-2007 - Tm Bioscience Corporation announced that Tm Bioscience shareholders and optionholders have approved the acquisition of Tm Bioscience by Luminex Corporation at the Company's Special Meeting of shareholders and optionholders. Shareholders and optionholders representing more than 98 percent of all ...

Luminex Corporation Announces Agreement to Acquire Tm Bioscience

19-Dec-2006 - Luminex Corporation and Tm Bioscience Corporation announced a definitive agreement for Luminex to acquire Tm Bioscience Corporation. Under the terms of the agreement, each Tm Bioscience share will be exchanged for 0.06 shares of Luminex common stock. The per share consideration represents a 41.5 ...